Novel and specific respiratory syncytial virus inhibitors that target virus fusion

被引:40
作者
Ding, WD
Mitsner, B
Krishnamurthy, G
Aulabaugh, A
Hess, CD
Zaccardi, J
Cutler, M
Feld, B
Gazumyan, A
Raifeld, Y
Nikitenko, A
Lang, SA
Gluzman, Y
O'Hara, B
Ellestad, GA [1 ]
机构
[1] Wyeth Ayerst Res, Dept Bioorgan Enzymol, Pearl River, NY 10965 USA
[2] Wyeth Ayerst Res, Dept Wyeth Lederle Vaccines & Pediat, Pearl River, NY 10965 USA
[3] Wyeth Ayerst Res, Dept Med Chem, Pearl River, NY 10965 USA
[4] Wyeth Ayerst Res, Dept Infect Dis, Pearl River, NY 10965 USA
关键词
D O I
10.1021/jm980239e
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:2671 / 2675
页数:5
相关论文
共 13 条
[1]  
Collins P.L., 1996, FIELDS VIROLOGY, V3, P1313
[2]   NUCLEOTIDE-SEQUENCE OF THE GENE ENCODING THE FUSION (F) GLYCOPROTEIN OF HUMAN RESPIRATORY SYNCYTIAL VIRUS [J].
COLLINS, PL ;
HUANG, YT ;
WERTZ, GW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (24) :7683-7687
[3]   POSTTRANSLATIONAL PROCESSING AND OLIGOMERIZATION OF THE FUSION GLYCOPROTEIN OF HUMAN RESPIRATORY SYNCYTIAL VIRUS [J].
COLLINS, PL ;
MOTTET, G .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :3095-3101
[4]   Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections [J].
DeClercq, E .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1996, 7 (03) :193-202
[5]   Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults [J].
Dowell, SF ;
Anderson, LJ ;
Gary, HE ;
Erdman, DD ;
Plouffe, JF ;
File, TM ;
Marston, BJ ;
Breiman, RF .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (03) :456-462
[6]   PROSPECTS FOR A RESPIRATORY SYNCYTIAL VIRUS-VACCINE [J].
HALL, CB .
SCIENCE, 1994, 265 (5177) :1393-1394
[7]   RESPIRATORY SYNCYTIAL AND PARAINFLUENZA VIRUSES [J].
HEILMAN, CA .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (03) :402-406
[8]   Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant [J].
Karron, RA ;
Buonagurio, DA ;
Georgiu, AF ;
Whitehead, SS ;
Adamus, JE ;
ClementsMann, ML ;
Harris, DO ;
Randolph, VB ;
Udem, SA ;
Murphy, BR ;
Sidhu, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13961-13966
[9]   Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation [J].
Lewinsohn, DM ;
Bowden, RA ;
Mattson, D ;
Crawford, SW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (11) :2555-2557
[10]   Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo [J].
Long, CE ;
Voter, KZ ;
Barker, WH ;
Hall, CB .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (11) :1023-1028